A method for producing an amorphous solid dispersion of at least one active pharmaceutical ingredient in a polymer matrix, wherein the polymer matrix comprises polyvinyl alcohol, comprising selecting a first polyvinyl alcohol having a first degree of hydrolysis, selecting a second polyvinyl alcohol having a second degree of hydrolysis which is lower than the first degree of hydrolysis, mixing the first polyvinyl alcohol, the second polyvinyl alcohol and the active pharmaceutical ingredient at a temperature above the glass transition temperature or melting temperature of the polymer matrix, thereby forming an amorphous solid dispersion of the active pharmaceutical ingredient.